NEXTCURE, INC. (NXTC)
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
PepsiCo Announces Timing and Availability of Second-Quarter 2026 Financial Results
VCI Global Provides Strategic Business Update as Institutional Shareholder Base Expands
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Nordson Corporation Declares Third Quarter Dividend for Fiscal Year 2026
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy
Aya Gold & Silver Releases its 2025 Sustainability Report
Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
Fifth Third for Business Helps Small Businesses Get Paid Faster, Manage Cash Flow, and Access Capital